Cargando…
Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
Autores principales: | Xu, Yun-chao, Liu, Xu, Li, Min, Li, Yan, Li, Chun-yan, Lu, Ying, Sanches, Jaceline, Wang, Lu, Du, Yue, Mao, Li-min, Zuo, Si-bo, Liu, Hui-ting, Shen, Jie, Wang, Bo, Hou, Li, Li, Lian-hong, Tang, Jian-wu, Ju, Jing-fang, Guan, Hong-wei, Song, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664391/ https://www.ncbi.nlm.nih.gov/pubmed/36420222 http://dx.doi.org/10.1016/j.omtn.2022.11.002 |
Ejemplares similares
-
A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
por: Xu, Yun-chao, et al.
Publicado: (2018) -
Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Li, Jiazhi, et al.
Publicado: (2022) -
Retraction notice to: Resveratrol attenuates lipopolysaccharide-induced dysfunction of blood-brain barrier in endothelial cells via AMPK activation
por: Hu, Min, et al.
Publicado: (2017) -
Retraction notice to “Long Noncoding RNA LINC01133 Functions as an
miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma” [Oncology
Research 26(3) (2018) 335–343]
por: Zeng, Hai-Feng, et al.
Publicado: (2022) -
Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2022)